Every device that reaches a patient carries the fingerprints of engineers who analyzed its risks, challenged its assumptions, and held it to the highest standard of evidence. At Rook Quality Systems, many of those engineers are women.
Medical devices don't become safe by accident. Behind every cleared product is a disciplined body of engineering work: risk analyses, design controls, usability studies, verification protocols, and regulatory documentation built with precision and purpose. That work is exacting, often invisible, and absolutely essential. At Rook, approximately 79% of our engineering team is women, bringing their expertise to every discipline that defines device quality in practice.
Women's History Month is an opportunity to recognize what has too often gone unrecognized: not just the presence of women in engineering, but the depth and consequence of their contributions. In a field where stakes are measured in patient outcomes, that recognition matters.
Engineering has never been short on women. It has been short on acknowledgement of them.
From the earliest days of biomedical instrumentation to the pioneering programmers who built the first clinical computing systems, women have shaped healthcare technology across every era. Their roles were often framed as support rather than authorship, documentation rather than design, a convenient narrative that obscured both their expertise and their authority.
Today, women engineers work across the full arc of medical device development, from early concept through post-market surveillance. Yet according to McKinsey and LeanIn.org’s Women in the Workplace 2025 report, for every 100 men promoted to manager, only 93 women are promoted. That broken rung at the first step up to leadership has persisted for eleven consecutive years, and the gap widens significantly for women of color. In a regulated industry where credibility is tied to who leads design reviews, who defines requirements, and who signs off on risk decisions, teams with greater gender diversity at every level produce more rigorous, better-challenged work.
Risk analysis. Design controls. Verification and validation. Usability engineering. Software quality. Regulatory documentation. These are the disciplines that define medical device quality in practice, and they are the disciplines where Rook’s women engineers work every day.
They support startups navigating their first regulatory submission and established manufacturers advancing the next generation of a device or software platform. Their work spans early feasibility through post-market evolution, determining whether a technology can be trusted before it ever reaches a clinical setting.
Much of this work is invisible to end users. Clinicians and patients will never see the hazard identified during a risk analysis, the use error designed out of an interface, or the verification protocol that confirmed device performance. But they benefit from all of it.
The change in how women engineers are represented and recognized in MedTech is real. It is also incomplete. Leadership parity in technical organizations remains distant. The pathways into senior engineering roles are still not equally accessible. And the cultural dynamics that have historically minimized women's contributions don't disappear simply because the workforce has changed.
What has changed is visibility. Women earlier in their careers can increasingly see themselves in these roles, and that matters. Representation shapes aspiration, and aspiration shapes pipeline.
At Rook, we are proud of the women engineers on our teams. Their work reflects what strong, rigorous, consequential engineering actually looks like. Their work is the reason devices are safer. Their voices are the reason our analyses are sharper. Their presence is the reason our teams are better.